Cancer News and Research

Latest Cancer News and Research

Scientists discover new metabolic pathway which makes gliomas more aggressive

A research alliance of Heidelberg University Hospital and the German Cancer Research Center, jointly with colleagues of the Helmholtz Center for Environmental Research in Leipzig, have discovered a new metabolic pathway which makes malignant brain tumors (gliomas) more aggressive and weakens patients' immune systems.

7 Oct 2011

Teriflunomide drug reduces relapse rate of people with MS

A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.

7 Oct 2011

New method employs Doppler ultrasound sensor to diagnose sinusitis

A new method of diagnosing sinusitis is presented in a new thesis from Lund University. The results offer the potential to reduce the use of antibiotics and the costs of the disease to society.

7 Oct 2011

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative - a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."

7 Oct 2011

Study shows Sox2 expression in many adult stem cells

Investigators at the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI) have found that Sox2 - one of the transcription factors used in the conversion of adult stem cells into induced pluripotent stem cells (iPSCs) - is expressed in many adult tissues where it had not been previously observed.

7 Oct 2011

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.

7 Oct 2011

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.

7 Oct 2011

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

A new study released this Wednesday revealed that breast cancer that is highly aggressive but caught early could be best treated with a combination of Herceptin and chemotherapy.

6 Oct 2011

Pregnant mums taking miscarriage prevention drug decades ago may have put their girls at risk of infertility and cancers

A new study reveals that a drug that was taken by millions of pregnant women decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems. The study shows that many of these daughters are now over 40 and may not even know of their risk if their mothers never realized or told them they had used the drug, a synthetic estrogen called DES or Diethyl stilbesterol.

6 Oct 2011

Vitamin D deficiency might be common in fair skinned people: Study

The British study suggests that pale people tend to be deficient in the “sunshine” vitamin and that without supplements they're unlikely to get their levels up without getting sunburned. That can put them at risk for bone loss, heart disease, and poorer survival from breast cancer, according to the study's authors.

5 Oct 2011

The male circumcision debate continues

Much has been written on the controversies and debates on whether males – from infants to adults – have a human right to retain their foreskin. The protestors have helped persuade 18 states to stop paying for circumcisions under their Medicaid health insurance programs.

5 Oct 2011

Blue Shield of California refuses to pay for breast cancer drug Avastin

In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.

4 Oct 2011

HPV may be responsible for the alarming numbers of oral cancers: Study

Sore throat for a very long time could be an early precursor of a sexually transmitted virus that is fueling a rise in oral cancer suggest researchers. Between 1988 and 2004, head, neck and throat cancers that tested positive for the human papilloma virus rose an astounding 225 percent, according to a new study.

4 Oct 2011

Australian project aims to improve the early detection of breast cancer

The University of Sydney, in partnership with BreastScreen NSW and Ziltron, has developed a pioneering web-based programme to monitor the performance of radiologists in detecting and diagnosing abnormalities in breast x-rays. Currently commencing its nationwide rollout, the BREAST Project has the potential to improve the early detection of breast cancer through screening and in turn reduce breast cancer mortality and morbidity.

4 Oct 2011

NCI's Center for Cancer Research awards $37 million recompete contract to Harris

Harris Corporation, an international communications and information technology company, has been awarded a $37 million recompete contract by the National Cancer Institute's Center for Cancer Research.

4 Oct 2011

First Edition: October 4, 2011

Today's news highlights include reports that the Supreme Court kicked off its new term by hearing a key Medicaid case that tests whether providers and patients can go to court to challenge decisions by cash-strapped states to reduce Medicaid payments.

4 Oct 2011

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.

4 Oct 2011

CRT, Cancer Research UK establish group of scientists with expertise in lipid metabolism

Cancer Research Technology, Cancer Research UK's commercial arm, has established a group of scientists with expertise in lipid metabolism - getting energy from fats and making building blocks for cell growth - to develop targets for potential new cancer drugs.

4 Oct 2011

Karo Bio initiates patient recruitment in eprotirome phase III trial for HeFH

The first patient has now been included in Karo Bio's phase III trial with eprotirome. A total of 630 patients with the hereditary condition HeFH will be studied for safety, and to confirm the beneficial effects on LDL-cholesterol that has been shown previously.

4 Oct 2011

Many average-risk women receive genetic testing for hereditary breast, ovarian cancers

Too many average-risk women and too few high-risk women receive genetic counseling and testing for hereditary breast and ovarian cancers, research shows. Experts at The University of Texas MD Anderson Cancer Center share advice to help patients and their doctors better evaluate family history and make more sound decisions about who should be tested.

4 Oct 2011

Cancer News and Research

Latest Cancer News and Research

Scientists discover new metabolic pathway which makes gliomas more aggressive

Teriflunomide drug reduces relapse rate of people with MS

New method employs Doppler ultrasound sensor to diagnose sinusitis

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

Study shows Sox2 expression in many adult stem cells

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

Pregnant mums taking miscarriage prevention drug decades ago may have put their girls at risk of infertility and cancers

Vitamin D deficiency might be common in fair skinned people: Study

The male circumcision debate continues

Blue Shield of California refuses to pay for breast cancer drug Avastin

HPV may be responsible for the alarming numbers of oral cancers: Study

Australian project aims to improve the early detection of breast cancer

NCI's Center for Cancer Research awards $37 million recompete contract to Harris

First Edition: October 4, 2011

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

CRT, Cancer Research UK establish group of scientists with expertise in lipid metabolism

Karo Bio initiates patient recruitment in eprotirome phase III trial for HeFH

Many average-risk women receive genetic testing for hereditary breast, ovarian cancers

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in